Inhibitor Therapeutics (INTI) holder makes 3.2M-share gift
Rhea-AI Filing Summary
Black Robe Capital LLC, a 10% owner of Inhibitor Therapeutics, Inc., together with Chief Financial Officer James A. McNulty as reporting persons, recorded a bona fide gift of 3,200,000 shares of common stock on July 1, 2026. Following this disposition, the reporting holder directly owned 19,901,057 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,200,000 shares
Net Sell
1 txn
Insider
Black Robe Capital LLC, MCNULTY JAMES A
Role
10% Owner | Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 3,200,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 19,901,057 shares (Direct)
Key Figures
Gifted shares: 3,200,000 shares
Transaction price per share: $0.0000
Shares owned after transaction: 19,901,057 shares
+2 more
5 metrics
Gifted shares
3,200,000 shares
Bona fide gift of common stock on July 1, 2026
Transaction price per share
$0.0000
Reported per-share price for the gifted shares
Shares owned after transaction
19,901,057 shares
Direct common stock holdings following the gift
Gift transactions
1
Number of bona fide gifts reported in this Form 4
Total gift shares (summary)
3,200,000 shares
Gift shares reported in the transaction summary
Key Terms
bona fide gift, ten percent owner, Common Stock
3 terms
bona fide gift financial
"The transaction code G was described as a bona fide gift."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
ten percent owner financial
"Black Robe Capital LLC was identified as a ten percent owner."
Common Stock financial
"The reported transaction involved shares of Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Inhibitor Therapeutics (INTI) report in this Form 4?
Inhibitor Therapeutics insiders reported a bona fide gift of 3,200,000 common shares. The transaction involved a disposition coded as “G,” indicating a gift transfer of stock rather than an open-market sale or purchase, and carried a reported price of $0.0000 per share.
Who are the reporting persons in the Inhibitor Therapeutics (INTI) insider gift filing?
The reporting persons are Black Robe Capital LLC, identified as a ten percent owner, and James A. McNulty, the company’s Chief Financial Officer. They jointly reported the bona fide gift of 3,200,000 common shares of Inhibitor Therapeutics, Inc.
Was the Inhibitor Therapeutics (INTI) insider gift under a Rule 10b5-1 trading plan?
The gift was not reported as made under a Rule 10b5-1 trading plan. The Rule 10b5-1 checkbox was left unmarked, indicating the disposition of 3,200,000 shares as a bona fide gift was not designated as pursuant to a pre-arranged trading arrangement.